Tissue selectivity¶
A drug's disproportionate concentration or effect in some tissues rather than others, arising from distribution barriers, transport, metabolism, receptor context, local activation, or biased pharmacodynamic response.
Core Idea¶
Tissue selectivity is the relative concentration or pharmacological effect of a drug in particular tissues compared with other tissues under a stated dose, route, time, and response measure. Perfusion, permeability barriers, transporters, plasma and tissue binding, local metabolism, receptor abundance, cofactors, and signaling context can alter exposure or convert the same ligand into different agonist or antagonist effects across tissues. The abstraction is therefore identified by a declared carrier, a transformation or constraint over that carrier, and an invariant that tells an analyst whether the named structure is genuinely present.
Scope of Application¶
Tissue selectivity belongs to pharmacology and is useful where the analyst can specify a defined drug or active metabolite, multiple tissues, exposure measurements, molecular targets, physiological responses, dose and time, and a comparison baseline, then evaluate selectivity is expressed as a comparative tissue-dependent exposure or effect under matched conditions and is traced to evidence rather than inferred from the drug's label alone. The scope is broad within that domain but bounded by the need for selectivity is expressed as a comparative tissue-dependent exposure or effect under matched conditions and is traced to evidence rather than inferred from the drug's label alone.
Clarity¶
The abstraction clarifies a crowded vocabulary by making selectivity is expressed as a comparative tissue-dependent exposure or effect under matched conditions and is traced to evidence rather than inferred from the drug's label alone the center of the account. A claim should name the carrier, the governing operation or relation, the applicable assumptions, and the recognition test. A bare label is insufficient because the name Tissue selectivity can be used for a formal identity, an implementation, or a neighboring result unless carrier and convention are stated.
Manages Complexity¶
Without the abstraction, an analyst must reason directly over many local details: the carrier roles, admissibility assumptions, competing conventions, derived invariants, boundary cases, and proof or validation obligations specific to Tissue selectivity. Tissue selectivity compresses them into the roles in the structural signature. That compression permits comparison across instances without erasing the variables that determine validity. It also exposes which details may be varied safely and which are constitutive.
Abstract Reasoning¶
- Identify the carrier. State what the elements, states, objects, or observations are: a defined drug or active metabolite, multiple tissues, exposure measurements, molecular targets, physiological responses, dose and time, and a comparison baseline. Reject examples whose alleged carrier belongs to a different problem.
- Lock the constitutive rule. Express selectivity is expressed as a comparative tissue-dependent exposure or effect under matched conditions and is traced to evidence rather than inferred from the drug's label alone independently of one notation or implementation.
Knowledge Transfer¶
Knowledge transfers strongly among subfields of pharmacology because they reuse a defined drug or active metabolite, multiple tissues, exposure measurements, molecular targets, physiological responses, dose and time, and a comparison baseline, Perfusion, permeability barriers, transporters, plasma and tissue binding, local metabolism, receptor abundance, cofactors, and signaling context can alter exposure or convert the same ligand into different agonist or antagonist effects across tissues., and type the carrier, state every parameter and convention in the definition, test that selectivity is expressed as a comparative tissue-dependent exposure or effect under matched conditions and is traced to evidence rather than inferred from the drug's label alone, compare the nearest accepted identity, and report counterexamples, uncertainty, and limiting cases.
Relationships to Other Abstractions¶
Current abstraction Tissue selectivity Domain-specific
Parents (1) — outgoing typed relations
-
Tissue selectivity is a kind of Selection Prime
The drug-system interaction produces selective access or response across tissue contexts.
Children (1) — abstractions linked here by typed relations
-
Targeted Drug Delivery Domain-specific presupposes Tissue selectivity
Targeted Drug Delivery presupposes Tissue Selectivity because the payload must achieve preferential exposure or effect at the declared biological target relative to off-target sites.
Hierarchy path (1) — routes to 1 parentless root
- Tissue selectivity → is a kind of Selection
Neighborhood in Abstraction Space¶
Tissue selectivity sits in a sparse region of the domain-specific corpus (66th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.
Family — Molecular & Developmental Biology Mechanisms (21 abstractions)
Nearest neighbors
- Biological pathway — 0.85
- Affinity electrophoresis — 0.85
- Epigenetics — 0.84
- Item analysis — 0.84
- Nocebo — 0.83
Computed from structural-signature embeddings · 2026-10-25